What is Toxoplasma gondii?
Toxoplasma gondii is an obligate intracellular protozoan parasite, which means that T. gondii is a unicellular eukaryote that survives by living in host cells. T. gondii is in the Apicomplexa family, which includes other protozoans such as Plasmodium species, the causative agents of malaria, and Cryptosporidium, a common cause of childhood diarrheal illnesses. All Apicomplexa have unique organelles at one end of the cell -the apical end -that are used for host cell invasion. Some Apicomplexa, such as T. gondii and the Plasmodium species, also have an apicoplast -a unique algae-derived organelle that is dedicated to specifi c metabolic functions, such as fatty-acid synthesis. 
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dissolves as the daughter cells fully form and separate. The tachyzoite is the fast replicating haploid form that disseminates throughout the host and at which the immune response is generally directed. In specifi c tissues and cell types, tachyzoites convert to bradyzoites -a slow replicating form that makes cysts. Cysts contain many bradyzoites and appear to evade the immune response, thus allowing T. gondii to establish a persistent infection for the life of the host. In humans, T. gondii encysts and persists in the brain and in cardiac and skeletal muscle. In both rodents and humans, the brain is the major organ for encystment. Defi nitive or intermediate hosts become infected by ingesting food or water contaminated with oocysts or tissue cysts. In addition, in humans, T. gondii can be passed from mother to fetus (congenital infection) and via contaminated organ transplants (heart).
How does T. gondii enter and survive in host cells? T. gondii invades host cells by inserting its so-called
'invasion machinery' into the host cell's plasma membrane. Unlike its cousin Plasmodium, T. gondii does not require a specifi c host receptor or protein to invade, thus explaining why it is capable of invading any nucleated host cell in vitro. During invasion, T. gondii enters the host cell while dragging host membrane with it. In so doing, the parasite becomes surrounded by the host membranes, and establishes a parasitopherous vacuole -the intracellular niche in which T. gondii then replicates asexually. The machinery for invasion is housed in several secretory organelles called micronemes and rhoptries (Figure 1 ). Whereas the micronemes primarily house proteins required for invasion and extracellular motility, the rhoptries contain proteins required for invasion, as well as for manipulation of the host cell (so called 'effector' proteins). The rhoptry effector proteins appear to primarily be released into the host cell at the time of invasion. A third type of secretory organelle in T. gondii are the dense granules. These contain different assortments of secreted proteins that can be released into the host cell at the time of invasion or after the establishment of the parasitopherous vacuole. Some of the proteins secreted by the rhoptries and Current Biology 28, R761-R783, July 23, 2018 R771 dense granules decorate the outside of the parasitopherous vacuole whereas others remain within the vacuole to serve an organizational role, including establishing a tubular network that allows the parasite to access the host cell cytoplasm.
What types of symptoms can T. gondii cause?
In humans with intact and well-developed immune responses, the vast majority of T. gondii infections are thought to be asymptomatic or produce a mild fl u-like illness at the time of acute infection. Most symptomatic disease caused by T. gondii relates to the parasite's tropism for, and persistence within, the brain, and primarily occurs in immunodefi cient individuals such as unborn fetuses or AIDS patients. In persons with intact immune systems, T. gondii can, in rare instances, cause a mononucleosislike illness and/or an infection of the retina, which developmentally is an outpouching of the brain. Although immune defi ciencies clearly predispose patients to symptomatic toxoplasmosis, emerging evidence suggests that the genotype of the infecting strain may also play a role in driving clinical outcomes. T. gondii is comprised of 15+ genetically distinct genotypes, which can be organized into 6 clades. Historically, the best studied and characterized of these strains are called type I, II, and III (haplotypes 1, 2, and 3, respectively). These three strain types were fi rst segregated by major differences in acute virulence in mice, with type I strains being completely lethal, type II strains being moderately lethal, and type III strains showing little lethality. In mice, the differences in acute virulence have been mapped to polymorphic alleles encoding effector proteins secreted from the rhoptries. How different T. gondii strains infl uence human disease is poorly understood at this time.
How does T. gondii enter the brain and which cells does it infect?
T. gondii likely enters the brain via the vasculature. As the brain capillary endothelial cells are joined by tight junctions, T. gondii must have a mechanism for crossing this so-called blood-brain barrier. Three mechanisms have been proposed to explain how T. gondii crosses the blood-brain barrier: paracellular entry; transcellular entry; or entry via an infected immune cell. Though T. gondii is capable of infecting any nucleated cell in vitro -including both neurons and glia (non-neuronal brain cells) -recent data suggest that T. gondii primarily infects and persists in neurons during in vivo infection. Which factors drive T. gondii's preferential interaction with neurons remain unknown at this time.
What does T. gondii do to the brain? Does it really affect behavior?
In immunocompetent rodents, a number of studies from different labs have shown that T. gondii infection can affect behavior. The behavioral effects range from decreased avoidance of cat urine (a predator) to overall reduced levels of anxiety. A number of mechanisms have been proposed to explain this change in rodent behavior: these include the specifi c neurons that are infected with cysts; changes in circuits secondary to infl ammation in the brain; and changes in systemic hormone levels. Currently, no defi nitive mechanism has been established, though the identifi cation of behavioral changes in mice infected with a non-persistent strain of T. gondii (that is, one that has not been observed to form cysts in the brain) suggests that cyst location does not drive the behavioral changes.
Although multiple groups have identifi ed behavioral changes in T. gondii-infected rodents, the data for whether T. gondii elicits human behavioral changes are much less consistent. Some investigators have noted that T. gondii seropositivity (that is, the presence of parasite antigens in blood that suggest prior infection with T. gondii) is enriched in conditions ranging from schizophrenia to Parkinson's disease and Alzheimer's disease. On the other hand, other investigators have found no association between T. gondii seropositivity and cognition. In addition, the prevalence of many disorders reported to be linked to T. gondii seropositivity (for example, schizophrenia) show the same prevalence in countries with high and low T. gondii seropositivity. In summary, for now, the link between T. gondii infection and changes in human behavior is inconsistent.
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